Register Today for ISPOR Webinar on NICE’s Strategic Approach to RWE and Novel Therapy Approval
July 8, 2021
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)’s next installment of its Signal series will take place July 15th at 11:00 AM EDT. The webinar will focus on the UK’s National Institute for Health and Care Excellence (NICE) is rethinking its approach to real world evidence (RWE) and evaluating novel therapies.
“Discover how NICE plans to speed up the existing evaluation pathway for new medicines by proactively identifying innovative and cost- effective health technologies, and by working closely with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and other partners in the UK healthcare ecosystem to ensure rapid UK access to pioneering new treatments post EU- exit, via the Innovative Licensing and Access Pathway.” Register here.
(Source: ISPOR, 2021)